<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39464776</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>29</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2046-1402</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>F1000Research</Title><ISOAbbreviation>F1000Res</ISOAbbreviation></Journal><ArticleTitle>The development of a roadmap for Health Technology Assessment implementation in Moldova.</ArticleTitle><Pagination><StartPage>518</StartPage><MedlinePgn>518</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">518</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.12688/f1000research.146025.2</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Moldova strives for universal health coverage (UHC) and considers health technology assessment (HTA) an important policy instrument to inform the choice of services that should be covered to progressively realize UHC. It plays a key role in determining which technologies are coved, considering various dimensions often including cost-effectiveness, budget impact, and feasibility. This paper reports on work undertaken to develop a roadmap for HTA implementation, using evidence-informed deliberative processes (EDPs) as the guiding framework.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Between 2020 and 2022, we undertook several activities that informed the roadmap. We conducted a needs assessment and an assessment of European HTA best practices using a combination of desk research, interviews and surveys. We then conducted a document review of six selected HTA systems, complimented by expert interviews from three neighbouring countries.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The roadmap provided a suggested HTA process, which included instructions on how to execute the different steps of the EDP framework to enhance the legitimacy of HTA-informed decision-making. The roadmap encompasses several aspects such as how to organize stakeholder involvement, how to identify and operationalize decision criteria, and how to make the decision process transparent. Guidance was given to the country on establishing a legal framework for HTA; a communication strategy; strengthening capacity and leveraging HTA expertise. The country was also given tailored advice on the positioning of the HTA-agency, first as an entity within the Ministry of Health or the National Agency of Public Health but with the long-term vision for it to be independent of any state institution.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Despite several challenges, including a partial disruption because of the Covid-19 pandemic, the development of the roadmap for HTA implementation was completed and agreed upon by the Ministry of Health in Moldova. This work has helped motivate and support the country in HTA institutionalization.</AbstractText><CopyrightInformation>Copyright: © 2024 Surgey G et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Surgey</LastName><ForeName>Gavin</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Health Economics and HIV and AIDS Research Division, University of KwaZulu-Natal, Durban, South Africa.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Global Health Priorities, RadboudUMC, Nijmegen, 6525 GA, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Curocichin</LastName><ForeName>Ghenadie</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-0613-4360</Identifier><AffiliationInfo><Affiliation>Nicolae Testemițanu State University of Medicine and Pharmacy, Chișinău, 2004, Moldova.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garabajiu</LastName><ForeName>Maria</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-6096-2100</Identifier><AffiliationInfo><Affiliation>Nicolae Testemițanu State University of Medicine and Pharmacy, Chișinău, 2004, Moldova.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Novakovic</LastName><ForeName>Tanja</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>ZEM Solutions Ltd, Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pana</LastName><ForeName>Adrian</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Independent, Bucharest, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oortwijn</LastName><ForeName>Wija</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0003-4499-8602</Identifier><AffiliationInfo><Affiliation>Global Health Priorities, RadboudUMC, Nijmegen, 6525 GA, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>F1000Res</MedlineTA><NlmUniqueID>101594320</NlmUniqueID><ISSNLinking>2046-1402</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008966" MajorTopicYN="N" Type="Geographic">Moldova</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013673" MajorTopicYN="Y">Technology Assessment, Biomedical</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003657" MajorTopicYN="N">Decision Making</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019472" MajorTopicYN="N">Universal Health Insurance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006291" MajorTopicYN="N">Health Policy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">HTA</Keyword><Keyword MajorTopicYN="N">Health Technology Assessment</Keyword><Keyword MajorTopicYN="N">Priority-setting; Roadmap; Moldova; EDPs; Evidence-informed deliberative processes</Keyword><Keyword MajorTopicYN="N">UHC</Keyword></KeywordList><CoiStatement>No competing interests were disclosed.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>28</Day><Hour>5</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39464776</ArticleId><ArticleId IdType="pmc">PMC11502998</ArticleId><ArticleId IdType="doi">10.12688/f1000research.146025.2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>O’Rourke B, Oortwijn W, Schuller T: The new definition of health technology assessment: A milestone in international collaboration. Int. J. Technol. Assess. Health Care. 2020 Jun;36(3):187–190. 10.1017/S0266462320000215</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0266462320000215</ArticleId><ArticleId IdType="pubmed">32398176</ArticleId></ArticleIdList></Reference><Reference><Citation>Oortwijn W, Jansen M, Baltussen R: Evidence-informed deliberative processes for health benefit package design–part II: a practical guide. Int. J. Health Policy Manag. 2022 Oct;11(10):2327. 10.34172/ijhpm.2021.159</Citation><ArticleIdList><ArticleId IdType="doi">10.34172/ijhpm.2021.159</ArticleId><ArticleId IdType="pmc">PMC9808268</ArticleId><ArticleId IdType="pubmed">34923809</ArticleId></ArticleIdList></Reference><Reference><Citation>Oortwijn W, Jansen M, Baltussen R: Evidence-informed deliberative processes. A practical guide for HTA bodies for legitimate benefit package design. Version 2.0. Nijmegen: Radboud University Medical Center;2021.</Citation></Reference><Reference><Citation>
World Bank. Overview - Moldova [Internet]. [cited 2023.03.01]. :
Reference Source
</Citation></Reference><Reference><Citation>World Health Organization: Health systems in action: Republic of Moldova: 2022 edition. 2022.</Citation></Reference><Reference><Citation>World Bank: World Development Indicators. Washington, DC: World Bank;2022.</Citation></Reference><Reference><Citation>Garam I, Zadnipru M, Doronin V, et al. : Can people afford to pay for health care? New evidence on financial protection in the Republic of Moldova. 2020.</Citation></Reference><Reference><Citation>Cylus J, Thomson S, Evetovits T: Catastrophic health spending in Europe: equity and policy implications of different calculation methods. Bull. World Health Organ. 2018;96(9):599–609. 10.2471/BLT.18.209031</Citation><ArticleIdList><ArticleId IdType="doi">10.2471/BLT.18.209031</ArticleId><ArticleId IdType="pmc">PMC6154073</ArticleId><ArticleId IdType="pubmed">30262941</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeffery M, Chi YL, Stewart M: iDSI Health Technology Assessment Toolkit [version 1; not peer reviewed]. F1000Res. 7(1545). 10.7490/f1000research.1116126.1</Citation><ArticleIdList><ArticleId IdType="doi">10.7490/f1000research.1116126.1</ArticleId></ArticleIdList></Reference><Reference><Citation>Baltussen R: Value assessment frameworks for HTA agencies: The organisation of evidence-informed deliberative processes. Value Health. 2017;20:256–260. 10.1016/j.jval.2016.11.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jval.2016.11.019</ArticleId><ArticleId IdType="pubmed">28237205</ArticleId></ArticleIdList></Reference><Reference><Citation>Oortwijn W, Jansen M, Baltussen R: Use of evidence-informed deliberative processes by health technology assessment agencies around the globe. Int. J. Health Policy Manag. 2020;9(1):27–33. 10.15171/ijhpm.2019.72</Citation><ArticleIdList><ArticleId IdType="doi">10.15171/ijhpm.2019.72</ArticleId><ArticleId IdType="pmc">PMC6943303</ArticleId><ArticleId IdType="pubmed">31902192</ArticleId></ArticleIdList></Reference><Reference><Citation>Nouhi M, Baltussen R, Razavi S, et al. : The use of evidence-informed deliberative processes for health insurance benefit package revision in Iran. Int. J. Health Policy Manag. 2022;11(11):2719–2726. 10.34172/ijhpm.2022.6485</Citation><ArticleIdList><ArticleId IdType="doi">10.34172/ijhpm.2022.6485</ArticleId><ArticleId IdType="pmc">PMC9818091</ArticleId><ArticleId IdType="pubmed">35247943</ArticleId></ArticleIdList></Reference><Reference><Citation>Oortwijn W, Surgey G, Novakovic T, et al. : The Use of Evidence-Informed Deliberative Processes for Health Benefit Package Design in Kazakhstan. Int. J. Environ. Res. Public Health. 2022 Sep 10;19(18):11412. 10.3390/ijerph191811412</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph191811412</ArticleId><ArticleId IdType="pmc">PMC9517624</ArticleId><ArticleId IdType="pubmed">36141691</ArticleId></ArticleIdList></Reference><Reference><Citation>Concannon T, Meissner P, Grunbaum J: A new taxonomy for stakeholder engagement in patient-centered outcomes research. J. Gen. Intern. Med. 2012;27(8):985–991. 10.1007/s11606-012-2037-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-012-2037-1</ArticleId><ArticleId IdType="pmc">PMC3403141</ArticleId><ArticleId IdType="pubmed">22528615</ArticleId></ArticleIdList></Reference><Reference><Citation>
Surgey G, Oortwijn W, Curocichin G, et al. :
Roadmap for HTA implementation in Moldova.[dataset].2024 [cited 2024 Mar 21].
Reference Source
</Citation></Reference><Reference><Citation>Oortwijn W, Oosterhout S, Kapiriri L: Application of evidence-informed deliberative processes in health technology assessment in low-and middle-income countries. Int. J. Technol. Assess. Health Care. 2020;36(4):440–444. 10.1017/S0266462320000549</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0266462320000549</ArticleId><ArticleId IdType="pubmed">32715993</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlad I: Stakeholder checklist for priority-setting in low and middle-income countries [version 1; not peer reviewed]. F1000Res. 2018;7:1718.</Citation></Reference><Reference><Citation>Surgey G, Mori AT, Baltussen R: Health Technology Assessment in Tanzania: Capacity and Experience of HTA Committee Members. J. Glob. Health Econ. Policy. 2022;2:e2022004. 10.52872/001c.33116</Citation><ArticleIdList><ArticleId IdType="doi">10.52872/001c.33116</ArticleId></ArticleIdList></Reference><Reference><Citation>Pichler F: Defining Capacity Building in the Context of HTA: A Proposal by the HTAi Scientific Development and Capacity Building Committee. Int. J. Technol. Assess. Health Care. 2019;35(5):362–366. 10.1017/S0266462319000631</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0266462319000631</ArticleId><ArticleId IdType="pubmed">31506132</ArticleId></ArticleIdList></Reference><Reference><Citation>Beletsi A, Koutrafouri V, Karampli E, et al. : Comparing use of health technology assessment in pharmaceutical policy among earlier and more recent adopters in the European Union. Value Health Reg Issues. 2018;16:81–91. 10.1016/j.vhri.2018.08.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vhri.2018.08.002</ArticleId><ArticleId IdType="pubmed">30316029</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization: Principles of Health Benefit Packages. Geneva: World Health Organization;2021.</Citation></Reference><Reference><Citation>Castro HE, Kumar R, Suharlim C: A Roadmap for Systematic Priority Setting and Health Technology Assessment (HTA). Arlington, VA: USAID/MSH;2020.</Citation></Reference><Reference><Citation>Bertram M, Dhaene G, Tan-Torres ET: Institutionalizing Health Technology Assessment Mechanisms: A How-to Guide. Bertram M, Dhaene G, Tan-Torres Edejer T, editors. Geneva: World Health Organization;2021.</Citation></Reference><Reference><Citation>Norheim O, Watkins D: The Role of HTA for Essential Health Benefit Package Design in Low or Middle-Income Countries. Health Syst. Reform. 2023;9(3):2273051. 10.1080/23288604.2023.2273051</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23288604.2023.2273051</ArticleId><ArticleId IdType="pubmed">37948391</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueller D: Addressing the challenges of implementing a Health Technology Assessment Policy framework in South Africa. Int. J. Technol. Assess. Health Care. 2020 Aug;36(4):453–458. 10.1017/S0266462320000562</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0266462320000562</ArticleId><ArticleId IdType="pubmed">32787995</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitton C, Smith N, Peacock S, et al. : Public participation in health care priority setting: a scoping review. Health Policy. 2009 Aug 1;91(3):219–228. 10.1016/j.healthpol.2009.01.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.healthpol.2009.01.005</ArticleId><ArticleId IdType="pubmed">19261347</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapiriri L, Baltussen R, Oortwijn W: Implementing evidence-informed deliberative processes in health technology assessment: a low income country perspective. Int. J. Technol. Assess. Health Care. 2020;36(1):29–33. 10.1017/S0266462319003398</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0266462319003398</ArticleId><ArticleId IdType="pubmed">31944173</ArticleId></ArticleIdList></Reference><Reference><Citation>Surgey G, Chalkidou K, Reuben W, et al. : Introducing health technology assessment in Tanzania. Int. J. Technol. Assess. Health Care. 2020;36(2):80–86. 10.1017/S0266462319000588</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0266462319000588</ArticleId><ArticleId IdType="pubmed">31402790</ArticleId></ArticleIdList></Reference><Reference><Citation>: Health technology assessment: A potential roadmap for India. International Journal of Medical Science and Public Health .2017; 10.5455/ijmsph.2017.1269225012017 10.5455/ijmsph.2017.1269225012017</Citation><ArticleIdList><ArticleId IdType="doi">10.5455/ijmsph.2017.1269225012017</ArticleId></ArticleIdList></Reference><Reference><Citation>: A SMART framework for HTA capability development: Lessons from India. Health Policy and Technology .2020;9(1) : 10.1016/j.hlpt.2019.12.001 42-44 10.1016/j.hlpt.2019.12.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hlpt.2019.12.001</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>